Influence of peritoneal fluid on the expression of angiogenic and proteolytic factors in cultures of endometrial cells from women with endometriosis

Human Reproduction

Volumn 25, Issue 2, 2010, Pages 398-405

  Cosin R ^a   Gilabert Estelles J ^a   Ramon L A ^a   Gomez Lechon M J ^a   Gilabert, J ^b   Chirivella, M ^a   Braza Boils A ^a   Espana F ^a   Estelles A ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL ARNAU DE VILANOVA   (Spain)

Author keywords

Angiogenesis; Endometrial cell culture; Endometriosis; Peritoneal fluid; Proteolysis

Indexed keywords

ANGIOGENIC FACTOR; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN; PROTEOLYTIC FACTOR; STROMELYSIN; THROMBOSPONDIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG; UROKINASE; VASCULOTROPIN A;

ADULT; ANGIOGENESIS; ARTICLE; CELL CULTURE; CELL ISOLATION; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE SEVERITY; ENDOMETRIOSIS; ENDOMETRIUM BIOPSY; ENDOMETRIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PERITONEAL FLUID; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN FUNCTION; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 74549138505     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dep419     Document Type: Article

References (37)

1. American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine Classification of Endometriosis: 1996. Fertil Steril 1997;67:817-821.
2. Bruse C, Bergqvist A, Carlstrom K, Fianu-Jonasson A, Lecander I, Astedt B. Fibrinolytic factors in endometriotic tissue, endometrium, peritoneal fluid, and plasma from women with endometriosis and in endometrium and peritoneal fluid from healthy women. Fertil Steril 1998;70:821-826.
3. Bruse C, Radu D, Bergqvist A. In situ localization of mRNA for the fibrinolytic factors uPA, PAI-1 and uPAR in endometriotic and endometrial tissue. Mol Hum Reprod 2004;10:159-166.
4. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9:653-660.
5. Castelló R, Estellés A, Vázquez C, Falcó C, España F, Almenar SM, Fuster C, Aznar J. Quantitative real-time reverse transcription-PCR assay for urokinase plasminogen activator, plasminogen activator Inhibitor type 1 (PAI-1) and tissue metalloproteinase inhibitor type 1 (TIMP-1) gene expression in primary breast cancer. Clin Chem 2002; 48:1288-1295.
6. Chung HW, Wen Y, Chun SH, Nezhat C, Woo BH, Polan ML. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness. Fertil Steril 2001;75:152-159.
7. Cośin R, Gilabert-Estellés J, Ramón LA, España F, Gilabert J, Romeu A, Estellés A. Vascular endothelial growth factor polymorphisms (2460C/T, +405G/C, and 936C/T) and endometriosis: their influence on vascular endothelial growth factor expression. Fertil Steril 2008; epub ahead of print 16 October 2008.
8. Cox KE, Piva M, Sharpe-Timms KL. Differential regulation of matrix metalloproteinase-3 gene expression in endometriotic lesions compared with endometrium. Biol Reprod 2001;65:1297-1303.
9. Donnez J, Smoes P, Gillerot S, Casanas-Roux F, Nisolle M. Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 1998; 13:1686-1690.
10. Fasciani A, D'Ambrogio G, Bocci G, Monti M, Genazzani AR, Artini PG. High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomata. Mol Hum Reprod 2000; 6:50-54.
11. Gilabert-Estellés J, Estellés A, Gilabert J, Castelló R, España F, Falcó C, Romeu A, Chirivella M, Zorio E, Aznar J. Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis. Hum Reprod 2003;18:1516-1522.
12. Gilabert-Estellés J, Castelló R, Gilabert J, Ramón LA, España F, Romeu A, Estellés A. Plasminogen activators and plasminogen activator inhibitors in endometriosis. Tissue remodeling factors in the physiology and pathophysiology of the female reproductive tract. Front Biosci 2005; 10:1162-1176.
13. Gilabert-Estellés J, Ramón LA, España F, Gilabert J, Vila V, Réganon E, Castelló R, Chirivella M, Estellés A. Expression of angiogenic factors in endometriosis: its relation to fibrinolytic and metalloproteinase (MMP) systems. Hum Reprod 2007;22:2120-2127.
14. Girling JE, Rogers PA. Recent advances in endometrial angiogenesis research. Angiogenesis 2005;8:89-99.
15. Giudice LC, Kao LC. Endometriosis. Lancet 2004;364:1789-1799.
16. Kawano Y, Nakamura S, Nasu K, Fukuda J, Narahara H, Miyakawa I. Expression and regulation of thrombospondin-1 by human endometrial stromal cells. Fertil Steril 2005;83:1056-1059.
17. Koninckx PR, Kennedy SH, Barlow DH. Endometriotic disease: the role of peritoneal fluid. Hum Reprod Update 1998;4:741-751.
18. Laschke MW, Menger MD. In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis. Hum Reprod Update 2007;13:331-342.
19. Laschke MW, Elitzsch A, Vollmar B, Vajkoczy P, Menger MD. Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions. Hum Reprod 2006; 21:262-268.
20. Lebovic DI, BentzienF,Chao VA, Garrett EN, Meng YG, Taylor RN. Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1beta. Mol Hum Reprod 2000;6:269-275.
21. Lembessis P, Milingos S, Michalas S, Milingos D, Creatsas G, Sourla A, Koutsilieris M. Urokinase-type plasminogen activator and insulin-like growth factor-binding protein 3 mRNA expression in endometriotic lesions and eutopic endometrium: implications for the pathophysiology of endometriosis. Ann NY Acad Sci 2003;997:223-228.
22. Lijnen HR. Matrix metalloproteinases and cellular fibrinolytic activity. Biochemistry 2002;67:92-98.
23. McLaren J. Vascular endothelial growth factor and endometriotic angiogenesis. Hum Reprod Update 2000;6:45-55.
24. McLaren J, Prentice A, Charnock-Jones DS, Smith SK. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod 1996; 11:220-223. (Pubitemid 26047702)
25. Na YJ, Yang SH, Baek DW, Lee DH, Kim KH, Choi YM, Oh ST, Hong YS, Kwak JY, Lee KS. Effects of peritoneal fluid from endometriosis patients on the release of vascular endothelial growth factor by neutrophils and monocytes. Hum Reprod 2006;21:1846-1855.
26. Osteen KG, Bruner KL, Sharpe-Timms KL. Steroid and growth factor regulation of matrix metalloproteinase expression and endometriosis. Semin Reprod Endocrinol 1996;14:247-255.
27. Pepper MS. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 2001;21:1104-1117.
28. Ramón L, Gilabert-Estellés J, Castelló R, Gilabert J, España F, Romeu A, Chirivella M, Aznar J, Estellés A. mRNA quantitative analysis of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis using real-time reverse transcription-PCR assay. Hum Reprod 2005;20:272-278.
29. Ryan IP, Eldon ED, Taylor RN. Isolation, characterization and comparison of human endometrial and endometriosis cells in vitro. J Clin Endocrinol Metab 1994;78:642-649.
30. Sampson JA. Peritoneal endometriosis due to menstrual dissemination of endometrial tissues into the peritoneal cavity. Am J Obstet Gynecol 1927; 14:422-469.
31. Sharpe-Timms KL. Endometrial anomalies in women with endometriosis. Ann NY Acad Sci 2001;943:131-147.
32. Sillem M, Prifti S, Koch A, Neher M, Jauckus J, Runnebaum B. Regulation of matrix metalloproteinases and their inhibitors in uterine endometrial cells of patients with and without endometriosis. Eur J Obstet Gynecol Reprod Biol 2001;95:167-174.
33. Takehara M, Ueda M, Yamashita Y, Terai Y, Hung YC, Ueki M. Vascular endothelial growth factor A and C gene expression in endometriosis. Hum Pathol 2004;35:1369-1375.
34. Tan XJ, Lang JH, Liu DY, Shen K, Leng JH, Zhu L. Expression of vascular endothelial growth factor and thrombospondin-1 mRNA in patients with endometriosis. Fertil Steril 2002;78:148-153.
35. Taylor RN, Lebovic DI, Mueller MD. Angiogenic factors in endometriosis. Ann NY Acad Sci 2002;955:89-100.
36. Ugwu F, Lemmens G, Collen D, Lijnen HR. Modulation of cell-associated plasminogen activation by stromelysin-1 (MMP-3). Thromb Haemost 1999;82:1127-1131.
37. Zorio E, Gilabert-Estelles J, Espana F, Ramon LA, Cośin R, Estelles A. Fibrinolysis: the key to new pathogenetic mechanisms. Curr Med Chem 2008; 15:923-929.